[1] Sung H, Ferlay J, Siegel RL, et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. [2] Zheng RS, Chen R, Han BF, et al.[Cancer incidence and mortality in China, 2022][J]. Zhonghua Zhong Liu Za Zhi, 2024, 46(3): 221-231. [3] Lau R, Gutierrez-Valencia E, Santiago A, et al.Surgical Resection Followed by Stereotactic Radiosurgery (S+SRS) Versus SRS Alone for Large Posterior Fossa Brain Metastases: A Comparative Analysis of Outcomes and Factors Guiding Treatment Modality Selection[J]. Brain Sci, 2024, 14(11): 1059. [4] 国家卫生健康委员会医政医管局, 中国抗癌协会脑胶质瘤专业委员会, 中国医师协会脑胶质瘤专业委员会. 脑胶质瘤诊疗指南(2022版)[J]. 中华神经外科杂志, 2022, 38(8): 757-777. [5] 石远凯, 孙燕, 于金明, 等. 中国肺癌脑转移诊治专家共识(2017年版)[J]. 中国肺癌杂志, 2017, 20(1): 1-13. [6] Essig M, Anzalone N, Combs SE, et al.MR imaging of neoplastic central nervous system lesions: review and recommendations for current practice[J]. AJNR Am J Neuroradiol, 2012, 33(5): 803-817. [7] Link TM, Patel R.The need for short MRI examinations: A musculoskeletal perspective[J]. J Magn Reson Imaging, 2019, 49(7): e49-e50. [8] Ellingson BM, Bendszus M, Boxerman J, et al.Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials[J]. Neuro Oncol, 2015, 17(9): 1188-1198. [9] Fan B, Li M, Wang X, et al.Diagnostic value of gadobutrol versus gadopentetate dimeglumine in enhanced MRI of brain metastases[J]. J Magn Reson Imaging, 2017, 45(6): 1827-1834. [10] Saini J, Gupta PK, Sahoo P, et al.Differentiation of grade II/III and grade IV glioma by combining “T1 contrast-enhanced brain perfusion imaging” and susceptibility-weighted quantitative imaging[J]. Neuroradiology, 2018, 60(1): 43-50. [11] Attenberger UI, Runge VM, Morelli JN, et al.Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3 T[J]. J Magn Reson Imaging, 2010, 31(3): 549-555. [12] Jeon J, Choi JW, Roh HG, et al.Effect of imaging time in the magnetic resonance detection of intracerebral metastases using single dose gadobutrol[J]. Korean J Radiol, 2014, 15(1): 145-150. [13] Koo TK, Li MY.A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research[J]. J Chiropr Med, 2016, 15(2): 155-163. [14] 康立丽, 卢广文, 余晓锷, 等. MRI扫描参数与信噪比关系的实验研究[J]. 中华放射学杂志, 2003, (3):33-35. [15] Chiang CW, Lin SY, Cho KH, et al.Effects of signal averaging, gradient encoding scheme, and spatial resolution on diffusion kurtosis imaging: An empirical study using 7T MRI[J]. J Magn Reson Imaging, 2019, 50(5):1593-1603. [16] Dietrich O, Raya JG, Reeder SB, et al.Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters[J]. J Magn Reson Imaging, 2007, 26(2): 375-385. [17] 翟艳慧, 孙楠楠, 王君鑫, 等. 3.0 T MR胃癌患者IVIM-DWI序列参数优化的初步研究[J]. 磁共振成像, 2021, 12(2): 34-37. [18] Heverhagen JT.Noise measurement and estimation in MR imaging experiments[J]. Radiology, 2007, 245(3): 638-639. [19] 李文俊, 冯菲菲. 不同NEX的零回波时间序列在颅底骨质中的应用探索[J]. 医学理论与实践, 2023, 36(20): 3526-3528. [20] 李希茂, 陶黎, 蔡焰, 等. 颅内血管壁成像中MSDE序列的参数优化研究[J]. 磁共振成像, 2022, 13(7): 112-115. [21] Hamasaki H, Shirasaka T, Ushijima Y, et al.Improvement of Image Quality Using Hybrid Iterative Reconstruction with Noise Power Spectrum Model in Computed Tomography During Hepatic Arteriography[J]. J Belg Soc Radiol, 2021, 105(1): 43. [22] 康立丽, 卢广文. 部分MR参数对信噪比影响实验研究[J]. 实用放射学杂志, 2003, (11):971-973. [23] Oliveira AC, Filipe HAL, Geraldes CFGC, et al.Interaction of MRI Contrast Agent [Gd(DOTA)]- with Lipid Membranes: A Molecular Dynamics Study[J]. Inorg Chem, 2024, 63(24): 10897-10914. [24] 陆洋, 柏根基. 定量动态增强磁共振成像及其在前列腺癌诊断和治疗中的研究进展[J]. 磁共振成像, 2015, 6(10): 796-800. [25] 金征宇, 薛华丹. 医学放射诊断学新进展[J]. 协和医学杂志, 2011, 2(3): 197-199. |